MYO-TRONICS' CHARGES OF FDA RETALIATION TO GET HHS IG AUDIT, KESSLER SAYS; REP. BARTON REQUESTS IG PROBE OF FDA RECEIPT OF PEDICLE SCREW DOCUMENTS
This article was originally published in The Gray Sheet
Executive Summary
Rep. Joe Barton's (R-Tex.) House Commerce/Oversight Subcommittee generated another device-related assignment for HHS' Inspector General at a Dec. 5 hearing, with FDA Commissioner David Kessler agreeing to ask the IG to investigate allegations of agency retaliation against dental products manufacturer Myo-tronics.
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.